Literature DB >> 31690663

MRTFB suppresses colorectal cancer development through regulating SPDL1 and MCAM.

Takahiro Kodama1,2,3, Teresa A Marian1,2, Hubert Lee1, Michiko Kodama1, Jian Li4, Michael S Parmacek4, Nancy A Jenkins1,5, Neal G Copeland6,5, Zhubo Wei6,2.   

Abstract

Myocardin-related transcription factor B (MRTFB) is a candidate tumor-suppressor gene identified in transposon mutagenesis screens of the intestine, liver, and pancreas. Using a combination of cell-based assays, in vivo tumor xenograft assays, and Mrtfb knockout mice, we demonstrate here that MRTFB is a human and mouse colorectal cancer (CRC) tumor suppressor that functions in part by inhibiting cell invasion and migration. To identify possible MRTFB transcriptional targets, we performed whole transcriptome RNA sequencing in MRTFB siRNA knockdown primary human colon cells and identified 15 differentially expressed genes. Among the top candidate tumor-suppressor targets were melanoma cell adhesion molecule (MCAM), a known tumor suppressor, and spindle apparatus coiled-coil protein 1 (SPDL1), which has no confirmed role in cancer. To determine whether these genes play a role in CRC, we knocked down the expression of MCAM and SPDL1 in human CRC cells and showed significantly increased invasion and migration of tumor cells. We also showed that Spdl1 expression is significantly down-regulated in Mrtfb knockout mouse intestine, while lower SPDL1 expression levels are significantly associated with reduced survival in CRC patients. Finally, we show that depletion of MCAM and SPDL1 in human CRC cells significantly increases tumor development in xenograft assays, further confirming their tumor-suppressive roles in CRC. Collectively, our findings demonstrate the tumor-suppressive role of MRTFB in CRC and identify several genes, including 2 tumor suppressors, that act downstream of MRTFB to regulate tumor growth and survival in CRC patients.

Entities:  

Keywords:  MRTFB; RNA-seq; SPDL1; colorectal cancer; tumor suppressor

Mesh:

Substances:

Year:  2019        PMID: 31690663      PMCID: PMC6876235          DOI: 10.1073/pnas.1910413116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  60 in total

1.  A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation.

Authors:  Alexander D Boiko; Sarah Porteous; Olga V Razorenova; Vadim I Krivokrysenko; Bryan R Williams; Andrei V Gudkov
Journal:  Genes Dev       Date:  2006-01-15       Impact factor: 11.361

2.  Requirement of myocardin-related transcription factor-B for remodeling of branchial arch arteries and smooth muscle differentiation.

Authors:  Jiyeon Oh; James A Richardson; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-04       Impact factor: 11.205

3.  Myocardin related transcription factors are required for coordinated cell cycle progression.

Authors:  Dmitry Shaposhnikov; Christian Kuffer; Zuzana Storchova; Guido Posern
Journal:  Cell Cycle       Date:  2013-05-08       Impact factor: 4.534

4.  MKL1 and MKL2 play redundant and crucial roles in megakaryocyte maturation and platelet formation.

Authors:  Elenoe C Smith; Jonathan N Thon; Matthew T Devine; Sharon Lin; Vincent P Schulz; Yanwen Guo; Stephanie A Massaro; Stephanie Halene; Patrick Gallagher; Joseph E Italiano; Diane S Krause
Journal:  Blood       Date:  2012-07-17       Impact factor: 22.113

5.  The transcriptional coactivators megakaryoblastic leukemia 1/2 mediate the effects of loss of the tumor suppressor deleted in liver cancer 1.

Authors:  S Muehlich; V Hampl; S Khalid; S Singer; N Frank; K Breuhahn; T Gudermann; R Prywes
Journal:  Oncogene       Date:  2011-12-05       Impact factor: 9.867

6.  Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: clinical and prognostic implications.

Authors:  Satyabrata Sinha; Ratnesh K Singh; Nilanjana Bhattacharya; Nupur Mukherjee; Susmita Ghosh; Neyaz Alam; Anup Roy; Susanta Roychoudhury; Chinmay Kumar Panda
Journal:  Mol Oncol       Date:  2011-07-07       Impact factor: 6.603

Review 7.  Cell adhesion molecules in the development and progression of malignant melanoma.

Authors:  J P Johnson
Journal:  Cancer Metastasis Rev       Date:  1999       Impact factor: 9.264

8.  A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity.

Authors:  Bartlomiej Waclaw; Ivana Bozic; Meredith E Pittman; Ralph H Hruban; Bert Vogelstein; Martin A Nowak
Journal:  Nature       Date:  2015-08-26       Impact factor: 49.962

9.  METCAM/MUC18 is a novel tumor and metastasis suppressor for the human ovarian cancer SKOV3 cells.

Authors:  Guang-Jer Wu; Guo-fang Zeng
Journal:  BMC Cancer       Date:  2016-02-22       Impact factor: 4.430

10.  Intensity modulated radiotherapy induces pro-inflammatory and pro-survival responses in prostate cancer patients.

Authors:  Houssein El-Saghire; Charlot Vandevoorde; Piet Ost; Pieter Monsieurs; Arlette Michaux; Gert De Meerleer; Sarah Baatout; Hubert Thierens
Journal:  Int J Oncol       Date:  2014-01-17       Impact factor: 5.650

View more
  11 in total

1.  Reply to Zhao et al.: NOMO1 is a potential target gene of MRTFB.

Authors:  Teresa A Marian; Zhubo Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-17       Impact factor: 11.205

2.  TMEM97 is transcriptionally activated by YY1 and promotes colorectal cancer progression via the GSK-3β/β-catenin signaling pathway.

Authors:  Dong Mao; Xiaowei Zhang; Zhaoping Wang; Guannan Xu; Yun Zhang
Journal:  Hum Cell       Date:  2022-07-30       Impact factor: 4.374

3.  Set1 Targets Genes with Essential Identity and Tumor-Suppressing Functions in Planarian Stem Cells.

Authors:  Prince Verma; Court K M Waterbury; Elizabeth M Duncan
Journal:  Genes (Basel)       Date:  2021-07-29       Impact factor: 4.096

4.  SPDL1 Overexpression Is Associated With the 18F-FDG PET/CT Metabolic Parameters, Prognosis, and Progression of Esophageal Cancer.

Authors:  Hua-Song Liu; Qiang Guo; Heng Yang; Min Zeng; Li-Qiang Xu; Qun-Xian Zhang; Hua Liu; Jia-Long Guo; Jun Zhang
Journal:  Front Genet       Date:  2022-05-18       Impact factor: 4.772

5.  Effect of Cetuximab-Conjugated Gold Nanoparticles on the Cytotoxicity and Phenotypic Evolution of Colorectal Cancer Cells.

Authors:  Ralph El Hallal; Nana Lyu; Yuling Wang
Journal:  Molecules       Date:  2021-01-22       Impact factor: 4.411

6.  Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis.

Authors:  Philip L Molyneaux; Adam Platt; Slavé Petrovski; Ryan S Dhindsa; Johan Mattsson; Abhishek Nag; Quanli Wang; Louise V Wain; Richard Allen; Eleanor M Wigmore; Kristina Ibanez; Dimitrios Vitsios; Sri V V Deevi; Sebastian Wasilewski; Maria Karlsson; Glenda Lassi; Henric Olsson; Daniel Muthas; Susan Monkley; Alex Mackay; Lynne Murray; Simon Young; Carolina Haefliger; Toby M Maher; Maria G Belvisi; Gisli Jenkins
Journal:  Commun Biol       Date:  2021-03-23

7.  Pan-cancer analysis combined with experiments explores the oncogenic role of spindle apparatus coiled-coil protein 1 (SPDL1).

Authors:  Peng Song; Dilinaer Wusiman; Fenglan Li; Xiaoxuan Wu; Lei Guo; Wenbin Li; Shugeng Gao; Jie He
Journal:  Cancer Cell Int       Date:  2022-01-29       Impact factor: 5.722

8.  A Cell Cycle-Related 13-mRNA Signature to Predict Prognosis in Hepatocellular Carcinoma.

Authors:  Yang Zhou; Dengliang Lei; Gangli Hu; Fang Luo
Journal:  Front Oncol       Date:  2022-03-28       Impact factor: 6.244

9.  SPDL1 Is an Independent Predictor of Patient Outcome in Colorectal Cancer.

Authors:  Anna Klimaszewska-Wiśniewska; Karolina Buchholz; Justyna Durślewicz; Emilly Schlee Villodre; Maciej Gagat; Dariusz Grzanka
Journal:  Int J Mol Sci       Date:  2022-02-05       Impact factor: 5.923

10.  MRTFB regulates the expression of NOMO1 in colon.

Authors:  Tianyi Zhao; Yang Hu; Tianyi Zang; Liang Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.